StockVS

BlackRock Capital Allocation Term Trust (BCAT) Stock Analysis

Financial Services

BlackRock Capital Allocation Term Trust

$15.64

+$0.12 (+0.77%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

BlackRock Capital Allocation Term Trust operates within the Financial Services sector, specifically focusing on the Asset Management industry where it oversees investment strategies and capital allocation for its portfolio. The company manages a significant market capitalization of $1.47 billion, reflecting its substantial presence in the financial markets, while specific figures for annual revenue and employee count are not disclosed in the available data. The absence of explicit employee count data precludes a direct assessment of workforce size, yet the substantial market capitalization suggests a mature entity with significant operational scale. This valuation indicates that the market attributes a high level of importance to the trust's capital allocation capabilities, positioning it as a major player despite the lack of granular operational metrics like revenue or headcount in the public record.

Financial Health

The financial statements for BlackRock Capital Allocation Term Trust report N/A for revenue, net income, and EBITDA, indicating that these specific line items are not disclosed or are aggregated in a manner that does not provide distinct standalone figures for the trust entity itself. Consequently, the gap between revenue and net income cannot be analyzed to reveal cost structures because neither metric is available for calculation. Similarly, free cash flow is reported as N/A, which means the company's financial flexibility regarding cash generation cannot be quantified using standard liquidity metrics. All three margins—gross margin, operating margin, and profit margin—are listed at 0.0%, a figure that typically signifies an investment vehicle structure where operating expenses are netted against investment returns at the trust level rather than reported as traditional operating margins. The total cash and total debt figures are both unavailable, making it impossible to determine if the balance sheet is conservative or leveraged based on absolute debt levels or cash reserves. The debt-to-equity ratio is also N/A, preventing an assessment of leverage, while the current ratio is not provided, leaving short-term liquidity standing undefined. Furthermore, return on equity and return on assets are not disclosed, so the effectiveness of management in generating returns on shareholder capital or total assets cannot be evaluated through these standard performance indicators.

Valuation Assessment

The trailing twelve-month P/E ratio is recorded at 6.60, whereas the forward P/E is N/A, suggesting that the market is valuing the current earnings without a projected trajectory for future earnings growth that would support a forward multiple. The price-to-book ratio is N/A, which prevents an analysis of whether the stock trades at a premium or discount relative to its tangible book value. Additionally, the price-to-sales ratio and EV/EBITDA are both unavailable, meaning alternative valuation metrics that might suggest different value propositions for the asset are not accessible for comparison. The stock has traded between a 52-week low of $12.91 and a 52-week high of $15.41, establishing a trading range where the current price position must be calculated relative to these fixed boundaries to understand recent market sentiment. The beta value is N/A, which precludes any assessment of the stock's price volatility relative to the broader market movements, leaving the risk profile regarding systemic market fluctuations undefined.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are both listed as N/A, indicating that historical growth rates are not available for analysis to determine if earnings are expanding faster or slower than revenue. The dividend yield stands at 22.1%, which is an exceptionally high figure for an equity instrument, while the payout ratio is 155.3%, meaning the declared dividends exceed the reported net income. Since the payout ratio is greater than 100%, the trust is distributing more income than it is currently generating in net profit, a structure common in certain investment trusts that may rely on capital appreciation or asset sales to fund distributions. Because the growth metrics are unavailable, a traditional analysis of whether the company reinvests earnings into growth versus paying dividends is limited to observing this high yield and unsustainable payout ratio based on current income. The overall growth and income profile is characterized by a very high current yield paired with undefined growth rates and a payout ratio that exceeds reported earnings, presenting a unique capital return dynamic for the asset.

Peer Comparison

BlackRock Capital Allocation Term Trust (BCAT) operates in the Asset Management industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
BlackRock Capital Allocation Term Trust BCAT $1.64B 7.4
BlackRock, Inc. BLK $167.25B 27.1
Blackstone Inc. BX $144.37B 30.3
Brookfield Corporation BN.TO $142.06B 89.6

The Asset Management industry average P/E ratio is 28.6x. BlackRock Capital Allocation Term Trust trades at a P/E of 7.4.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

Key Statistics

Market Cap
$1.64B
P/E Ratio
7.38
52-Week High
$15.89
52-Week Low
$13.73
Avg Volume
706.46K
Dividend Yield
19.79%

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United States